Lilly’s stock rallies as sales of GLP-1 drugs nearly double
Eli Lilly said its tirzepatide franchise had another stellar quarter.
Original Source
Read the full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.